In Re: Nuvasive, Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
TARANTO, Circuit Judge.
NuVasive, Inc. owns U.S. Patent No. 8,187,334, which describes and claims implants for spinal fusion surgery. Medtronic, Inc,—which settled with NuVasive and has withdrawn from the present appeals—filed two petitions for inter partes review with the Patent and Trademark Office, which the Patent Trial and Appeal Board instituted as IPR2013-507 (IPR507) and IPR2013-508 (IPR508). The Board ultimately cancelled all but one'of the challenged claims under 35 U.S.C. § 103, finding in one prior-art reference, ie., Michelson’s U.S. Patent No. 5,860,973, a spina! fusion implant…
2Cases cited8 opinions
- Belden Inc. v. Berk-Tek LLCCourt of Appeals for the Federal Circuit · 2015
- In Re Magnum Oil Tools International, Ltd.Court of Appeals for the Federal Circuit · 2016
- Genzyme Therapeutic Products Ltd. Partnership v. Biomarin Pharmaceutical Inc.Court of Appeals for the Federal Circuit · 2016
- In Re Sujeet KumarCourt of Appeals for the Federal Circuit · 2005
- Dell Inc. v. Acceleron, LLC.Court of Appeals for the Federal Circuit · 2016
3 more not listed; retrieve them via the Exa API.
3Cited by24 opinions
- Rovalma, S.A. v. Bohler-Edelstahl Gmbh & Co. KgCourt of Appeals for the Federal Circuit · 2017
- Anacor Pharmaceuticals, Inc. v. IancuCourt of Appeals for the Federal Circuit · 2018
- EmeraChem Holdings, LLC v. Volkswagen Group of America, Inc.Court of Appeals for the Federal Circuit · 2017
- Nike, Inc. v. Adidas AgCourt of Appeals for the Federal Circuit · 2020
- Corephotonics, Ltd. v. Apple Inc.Court of Appeals for the Federal Circuit · 2023
19 more not listed; retrieve them via the Exa API.